key: cord-1026363-m9r48jcp
authors: Sepe, Sara; Rossiello, Francesca; Cancila, Valeria; Iannelli, Fabio; Matti, Valentina; Cicio, Giada; Cabrini, Matteo; Marinelli, Eugenia; Alabi, Busola; di Lillo, Alessia; Di Napoli, Arianna; Shay, Jerry W.; Tripodo, Claudio; d’Adda di Fagagna, Fabrizio
title: DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging
date: 2021-06-09
journal: bioRxiv
DOI: 10.1101/2021.06.09.447484
sha: 72af1c6caf07741d1bf894fe1f8ec36a6980d2d9
doc_id: 1026363
cord_uid: m9r48jcp

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is known to be more common in the elderly, who show also more severe symptoms and a higher risk of hospitalization and death. Here we show that the expression of the Angiotensin Converting Enzyme 2 (ACE2), the SARS-CoV2 cell receptor, increases during aging in mouse and human lungs, and following telomere shortening or dysfunction in mammalian cells and in mouse models. This increase is regulated at the transcription level, and Ace2 promoter activity is DNA damage response (DDR)-dependent. Indeed, ATM inhibition or the selective inhibition of telomeric DDR, through the use of antisense oligonucleotides, prevents Ace2 upregulation following telomere damage, in cultured cells and in mice. We propose that during aging telomeric shortening, by triggering DDR activation, causes the upregulation of ACE2, the SARS-CoV2 cell receptor, thus making the elderly likely more susceptible to the infection.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the recent coronavirus disease 2019 pandemic. The clinical course of the disease is variable, ranging from asymptomatic infection to multi-organ failure and death, with a fatality rate of ~5%. The severity of the infection has been correlated with the age of patients, suggesting that aging is an important risk factor influencing the outcome (Verity et al, 2020) . The reasons for the development of severe symptoms in the elderly compared to young individuals are still under intense investigation. The expression of angiotensin-converting enzyme 2 (ACE2), which works as the host functional receptor for SARS-CoV-2 (Yan R et al, 2020) (Lan et al, 2020) , has been positively related to patients' age (Beyerstedt et al, 2021) , although some reports question the effective increase of ACE2 levels during aging (Xudong et al, 2006) .

In order to better clarify the modulation of the ACE2 expression during aging, and the potential molecular mechanisms underlying it, we studied the expression of ACE2 in mouse and human lungs at different ages.

We observed an increase of Ace2 mRNA levels ( Fig 1A) in lungs of aged mice (22) (23) (24) months) compared to young mice (2-3 months) as detected by RT-qPCR. Immunohistochemistry (IHC) analyses of the same lungs confirmed and extended this observation to the protein level. ACE2 protein was detected in both pneumocytic and stromal/inflammatory elements in the lungs of old mice (Fig 1B) . Quantitative analysis of IHC labeling showed a significant increase in terms of density of expression in old mice, as compared with young mice (Fig 1B) .

Prompted by the detection of ACE2 different expression levels in lungs from young and old mice, we extended our analyses to human lung tissue samples by comparing ACE2 immunostaining in histologically normal lung parenchyma of young (20-35 years old) subjects and old (60-80 years old) subjects. ACE2 protein expression levels in the lung parenchyma of old subjects proved to be higher as compared with that of young subjects, as shown and quantified in Fig 1C. Emerging evidence suggests that the severity of SARS-CoV-2 infection correlates with high rates of alveolar epithelial type II (ATII) cells infection (Yee et al, 2020) . We took advantage of the single-cell transcriptomic mouse atlas spanning different ages (Almanzar et al, 2020) and focused on the expression data of lungs. We observed that, while housekeeping genes such as Gapdh are widely expressed in almost all cell types, Ace2 showed an ATII pneumocytes-preferential expression that increased upon aging (Fig 1D and EV1A ). These conclusions are consistent with similar analyses performed on non-human primates (Ziegler et al, 2020) .

To confirm that ACE2-expressing elements were actually ATII cells, we performed double-marker immunofluorescence for ACE2 and pro-SP-C in mice or TTF-1 in human lung samples of different ages. Immunofluorescence revealed that ACE2 was predominantly expressed in ATII pneumocytes and it increased with aging (Figs 1E-F).

These results indicate that ACE2 expression is upregulated with age in lungs, thus likely favoring infection by SARS-CoV-2 and causing more severe symptoms.

Aging is associated with telomere shortening and damage in several tissues (Vaiserman & Krasnienkov, 2021) (Demanelis et al, 2020) (Fumagalli et al, 2012) (Hewitt et al, 2012) .

To test if telomere shortening can modulate ACE2 expression, we monitored its mRNA levels in human fibroblasts (BJ) and human bronchial epithelial cells (HBECs) at different population doublings since both cell types do not have telomere maintenance mechanisms and are characterized by progressive telomere shortening upon proliferation (Huffman et al, 2000 )(Peters-Hall et al, 2018 . Both late passage BJ and HBEC had increased levels of ACE2 mRNA, compared to cells at early passages (Fig 2A-B) .

Recently, a shorter ACE2 splicing isoform has been described and proposed to be upregulated by interferon response upon infection by different viruses (but not upon SARS-Cov-2). Since the shorter splice isoform lacks the extracellular domain, that is used as SARS-CoV-2 binding site, it is not relevant for SARS-CoV-2 infection (Blume et al, 2021) . The observed increase in late passages BJ cells was not due to this short isoform, since primers specific for the long isoform (see materials and methods section) detected a similar increase in RT-qPCR assays (Fig EV1B) , while the short isoform was below detection levels (data not shown).

We extended our studies to a mouse model lacking the RNA component of telomerase (Terc -/-), which at late generations recapitulates several features of human aging in different tissues (Lee et al, 1998) (Rudolph et al, 1999) (Giorgio et al, 2016) , including lungs (Piñeiro-Hermida et al, 2020) . When we analyzed the expression level and the distribution of ACE2 protein in the lungs of the third generation (G3) of Terc -/mice at 12 months of age and in age-and sex-matched wild type animals, we observed a consistent increase of ACE2 expression in G3 Terc -/mice when compared to wild type counterparts ( Fig 2C) . Immunofluorescence imaging with specific cell markers demonstrated that ACE2 increases mainly in ATII pneumocytes expressing pro-SP-C ( Fig 2D) .

When telomeres become critically short, they activate the DNA damage response (DDR) pathway (D'Adda Di Fagagna et al, 2003) (Herbig et al, 2004) . To test if telomeric DDR is sufficient to increase ACE2 mRNA levels, we used two mammalian cell systems, which allow the activation of the DDR specifically at telomeres, in the absence of telomere shortening. TRF2 is a component of the shelterin complex and prevents telomeric DNA from being recognized as a DNA lesion and activate a DDR (Palm & De Lange, 2008) .

We used Trf2 conditional knockout mouse embryonic fibroblasts (MEFs Trf2 F/F ) carrying a Cre recombinase (Rosa26-CreERT2) inducible by 4-hydroxytamoxifen (4OHT) (Okamoto et al, 2013) and HeLa cells with a doxycycline-regulated expression of a short hairpin against TRF2 (HeLa shTRF2) to knockdown TRF2 expression (Grolimund et al, 2013) .

TRF2 knockout or knockdown led to telomeric DDR activation as shown by foci of DDR markers at telomeres and increased levels of telomeric damage-induced long non-coding RNA (tdilncRNA) (Aguado et al, 2019) (Rossiello et al, 2017) in both cell lines (Figs 3A,C and EV2A). Here, we observed a correlation between DDR increase and ACE2 mRNA levels (Figs 3B,D). Interestingly, DDR activation following ionizing radiation (IR) in the same cell lines (Figs EV2B,D) drove a similar increase of ACE2 mRNA levels (Figs EV2C,E), indicating that while telomeric DDR activation is the most likely event increasing ACE2 levels during physiological aging, additional events activating DDR could also contribute. To verify the effects of telomeric DDR in vivo, we next used an inducible Trf2 knockout mouse model (Trf2 fl/fl mice) (Rossiello et al, 2017) in which, following tamoxifen administration, Trf2 expression is lost, leading to DDR activation at telomeres as shown by the accumulation of foci of 53BP1, a robust marker of DDR activation ( Fig 3E) . Parallel to DDR activation, we observed an increase of Ace2 mRNA levels in mouse tissues upon tamoxifen administration (Fig 3F) , demonstrating that also in vivo the activation of DDR at telomere leads to increased Ace2 expression.

Taken together, these results in human and mouse cell lines and in mouse tissues indicate a role for the activated DDR pathways in the increase of ACE2 levels.

The increase of mRNA levels can be caused by a regulated process at the ACE2 transcriptional promoter level. In order to determine whether the ACE2 promoter could respond to DDR activation, we first performed an in silico analysis to identify the transcription factors DNA binding motifs significantly enriched in the promoter region of ACE2. Gene set enrichment analysis of the top 100 transcription factors potentially associated with the ACE2 promoter, revealed an over-representation of pathways possibly related to the DNA damage response (Fig 4A) .

To experimentally demonstrate that the ACE2 promoter responds to the activation of the DDR pathways, we transfected a plasmid carrying the luciferase gene as a reporter under the control of human ACE2 promoter in HeLa shTRF2 cells and we induced telomeric DDR by TRF2 knockdown. Importantly, we observed an increase of luciferase signal upon telomere dysfunction. A similar transcriptional activation was also observed also upon exposure of uninduced HeLa cells to IR ( Fig 4B) .

To demonstrate that DDR pathway activation is directly responsible for the observed increase in Ace2 mRNA levels, we treated MEFs Trf2 F/F with the ATM kinase inhibitor KU-60019 (ATMi) while inducing Trf2 knockout by 4OHT treatment. While, as expected, this treatment prevented the DDR foci formation (Fig 5A) , it also significantly reduced Ace2 mRNA levels increase (Fig 5B) , demonstrating ATM kinase activity involvement in Ace2 transcripts levels.

In order to investigate if inhibition of DDR could affect the expression of ACE2 also in vivo, we took advantage of telomeric antisense oligonucleotides (tASOs), which allow the specific inhibition of telomeric DDR by targeting tdilncRNA generated at dysfunctional telomeres and necessary for full DDR activation at telomeres (Michelini et al, 2017) 6 (Rossiello et al, 2017) (Aguado et al, 2019) . To test the impact of selective telomeric DDR inhibition on ACE2 expression, following tamoxifen-induced Trf2 loss, mice were treated with a systemic dose of anti-teloG or anti-teloC ASOs, or phosphate-buffered saline (PBS) as negative control, delivered by intraperitoneal injection. Four days later, when telomeric DDR reached maximal activation in this model, mice were sacrificed and the liver was analysed. Both tASO treatments were highly effective, as demonstrated by decreased number of 53BP1 foci ( Fig 5C) as previously shown (Rossiello et al, 2017) , and led to Ace2 mRNA levels downregulation in vivo ( Fig 5D) . Stimulated by this result, we then extended our studies to the G3 Terc -/mouse model of telomere shortening and dysfunction. We treated 3 months old G3 Terc -/mice with anti-teloG or anti-teloC ASOs or an ASO with an unrelated sequence (Control) by intraperitoneal injection and we sacrificed them at 12 months of age to collect their lungs.

Quantitative immunohistochemical analyses of ACE2 expression revealed high levels of the protein in Control G3 Terc -/mice, compared to age-and sex-matched wild type animals. Such an expression was significantly dampened by the treatment with either tASOs (Fig 5E) , which impacted on ACE2 expression mainly in pro-SP-C-expressing pneumocytic elements, as shown by double-marker immunofluorescence ( Fig 5F) . These experiments also indicate that, rather than telomeric shortening per se, it is the ensuing DDR activation that is responsible for ACE2 regulation.

Taken together, these results clearly demonstrate that the expression of ACE2, the SARS-CoV-2 receptor, is directly modulated by the activation of the DDR pathway at the transcriptional level, and that telomere dysfunction is a physiological event able to engage the DDR pathways modulating ACE2 levels. Our results also demonstrate that tASOs are agents effective in controlling ACE2 levels in vivo in mouse tissues, including the lung. In perspective, as ASOs are established medicines approved for a number of disorders (Crooke et al, 2021) and as telomeric DDR increases with age in normal and pathological conditions (Rossiello et al, Nature Cell Biology, under submission) we suggest that, upon additional validation, tASOs can have a potential as therapeutic agents to reduce susceptibility to SARS-CoV-2 infection.

Foreskin fibroblast BJ cells (The American Type Culture Collection) were grown in MEM supplemented with 10% fetal bovine serum, 1% glutamine, 10 mM non-essential amino acids and 1 mM sodium pyruvate.

Primary Human bronchial epithelial cells (HBECs) were co-cultured with irradiated 3T3 J2 feeder cells with ROCK inhibitor and 2% O2 (ROCKi conditions) as described previously (Peters-Hall et al, 2018) . (Okamoto et al, 2013) , a kind gift from Eros Lazzerini Denchi (National Cancer Institute, NIH, Bethesda, USA), were grown in DMEM supplemented with 10% fetal bovine serum and 1% glutamine; for CreER activation, cells were treated with 600nM 4 hydroxytamoxifen (4OHT, H7904, Sigma-Aldrich).

HeLa inducible shTRF2 cells (Grolimund et al, 2013) , a gift from Joachim Lingner (ISREC-EPFL, Lausanne, Switzerland), expressing the tTR-KRAB construct, the dsRED marker and the doxycycline-inducible shTRF2 and GFP marker, were grown in DMEM supplemented with 10% Tet System Approved fetal bovine serum and 1% glutamine; for shTRF2 and GFP induction, cells were treated with doxycycline (1 μg ml -1 ).

All cell lines used in this study were grown under standard cell culture conditions (37°C, 5% CO2) and were tested negative for mycoplasma contaminations.

Ionizing radiation was induced by a high-voltage X-ray-generator tube (Faxitron X-Ray Corporation).

ATM kinase inhibitor KU-60019 (S1570 Selleckchem), or dimethylsulphoxide as negative control, was used at 10 μM concentration.

Experiments involving animals have been done in accordance with the Italian Laws For the analysis of young and old mice, C57BL/6 J mice were purchased from the Charles River Laboratories. Young animals were sacrificed at 2-3 months of age, while old animals at 22-24 months of age. After collection, lungs were snap frozen for RNA extraction and formalin-fixed and paraffin embedded for histological analysis.

Terc mice (B6.Cg-Terctm1Rdp/J Stock No: 004132 | mTR -/-) (Blasco et al, 1997) were purchased by Jackson Laboratory. Terc +/− mice were intercrossed to generate firstgeneration (G1) homozygous Terc −/− knockout mice. Second-generation (G2) Terc −/− mice were generated by successive breeding of G1 Terc −/− and then G3 Terc −/− mice by crosses between G2 Terc −/− mice. Finally, wild type C57BL/6J and G3 Tert −/− mice were used for the experiments. The 8-10 weeks-old mice were injected intraperitoneally (i.p.) with a Control, ASO anti-teloG and ASO anti-teloC at a final concentration of 15 mg/kg twice a week for four weeks. The animals were sacrificed at 12 months of age. The lungs were collected and part of it was snap frozen for RNA extraction and part was washed in PBS and collected for fixation in 10% neutral buffered formalin overnight, washed in water and paraffin-embedded for histological analysis.

Rosa26-CreERT mice (Jackson Laboratory) and TRF2 conditional knockout mice (Celli & de Lange, 2005) 

Human lung tissue samples were collected from the archives of the Department of Clinical and Molecular Medicine, Pathology Unit, Sant'Andrea Hospital, Sapienza University, Rome, Italy. Samples were relative to histologically normal parenchyma adjacent to either foci of subpleural emphysema (young subjects) or non-small cell lung cancer (old subjects). The samples were collected and handled according to the Helsinki Declaration.

Patients provided written informed consent to the use of their tissue samples for research purposes (Ethical Approval SA250).

The locked nucleic acid-modified oligonucleotides with a fully phosphorothioate backbone were produced by Qiagen as described (Rossiello et al, 2017) .

Sequences were as follows (5'-3' orientation):

Control: ACTGATAGGGAGTGGTAAACT anti-teloG: CCCTAACCCTAACCCTAACCC anti-teloC: GGGTTAGGGTTAGGGTTAGGG

Four-micrometers-thick human and mouse tissue sections were deparaffinized, rehydrated and unmasked using Novocastra Epitope Retrieval Solutions pH8 in thermostatic bath at 98°C for 30 minutes. Subsequently, the sections were brought to room temperature and washed in PBS. After neutralization of the endogenous peroxidase with 3% H2O2 and Fc blocking by a specific protein block (Leica Novocastra), the samples were incubated with the primary antibodies.

IHC staining was revealed using Novolink Polymer Detection Systems (Leica Novocastra) or IgG (H&L) specific secondary antibodies (Life Technologies, 1:500) and DAB (3,3'-Diaminobenzidine, Leica Novocastra) as substrate chromogen.

For multiple-marker immunostainings, sections were incubated with ACE2 and TTF-1 primary antibodies and the binding of the primary antibodies to their respective antigenic substrates was revealed by made-specific secondary antibodies conjugated with Alexa-488 (Life Technologies, 1:250) and Alexa-568 (Life Technologies, 1:300) fluorochromes.

In order to multiplex antibodies raised in the same species (ACE2 and Prosurfactant Protein C), Opal Multiplex IHC kit was developed. After deparaffinization, antigen retrieval in pH8 buffer was brought to a boil at 100% power, followed by 20% power for 15 minutes using microwave technology (MWT). Sections were treated with blocking buffer for 10 minutes at room temperature before primary antibody incubation. Slides were then incubated with Polymeric horseradish peroxidase-conjugated (HRP) secondary antibody for 10 minutes and the signal was visualized using Opal 520 fluorophore-conjugated tyramide signal amplification (TSA) at 1:100 dilution. The HRP catalyze covalent deposition of fluorophores around the marker of interest. The slides were again processed with the microwave treatment to strip primary/secondary antibody complex and allow the next antigen-antibody staining. Another round of staining was performed with the second primary antibody incubation, followed by Polymeric horseradish peroxidase-conjugated (HRP) secondary antibody and Opal 620 fluorophore-conjugated tyramide signal amplification (TSA) at 1:100 dilution for signal visualization. Finally, slides were again microwaved in antigen retrieval buffer and nuclei were subsequently visualized with DAPI (4',6-diamidin-2-fenilindolo).

Slides were analyzed under a Zeiss Axioscope A1 microscope equipped with four fluorescence channels widefield IF. Microphotographs were collected using a Zeiss Axiocam 503 Color digital camera with the Zen 2.0 Software (Zeiss).

Quantitative analyses of immunohistochemical stainings were performed by calculating the average percentage of positive signals in five non-overlapping fields at medium-power magnification (x200) using the Positive Pixel Count v9 Leica Software Image Analysis.

A measure of 4-mm tissue sections were fixed for 10 min in 4% PFA, incubated in blocking solution (2% BSA, 0.1% Tween in PBS) for 1 hour at RT. Then sections were incubated for 1 h at RT with primary antibodies, washed in blocking solution and incubated for 1 h at RT with secondary antibody. Nuclei were stained with DAPI (1 mg ml -1 ). Samples were mounted with glycerol solution. Image acquisition was performed in a Leica TCS SP5 confocal microscope. The detection parameters were set in the control samples and were kept constant across specimens.

Cells were fixed with 4% PFA. After incubation with blocking solution, cells were stained with primary antibody for 1 h at RT, washed and incubated with secondary antibodies for 40 min at RT. Nuclei were stained with 4,6-diamidino-2-pheny-lindole (DAPI; 1 mg ml -1 ).

Samples were mounted in mowiol. Image acquisition was performed in a Leica AOBS SP2 confocal microscope. The detection parameters were set in the control samples and were kept constant across specimens.

After the immunofluorescence protocol, cells were treated as described (https://bioprotocol.org/e999). Briefly, after incubation with the secondary antibodies, cells were washed, fixed with PFA 4% + triton 0.1% for 10 min RT, incubated with glycine 10 mM for 30 min RT, washed, denatured at 80°C for 5 min and incubated with Cy5-conjugated TelC PNA probe (F1003 -Panagene). After washes, nuclei were stained with 4,6-diamidino-2pheny-lindole (DAPI; 1 mg ml -1 ). Samples were mounted in mowiol. Image acquisition was performed in a Leica AOBS SP2 confocal microscope. The detection parameters were set in the control samples and were kept constant across specimens.

The following primary antibodies were adopted for IHC and IF on mouse and human tissues: rabbit polyclonal ACE2 (1:500 pH8, ab15348, Abcam), rabbit polyclonal Prosurfactant Protein C (1:200 pH9, AB3786, Merck Millipore), mouse monoclonal TTF-1 (clone SPT24, 1:100 pH6, NCL-L-TTF-1, Leica Novocastra), rabbit polyclonal anti-53BP1 (1:1000, sc-22760, Santa Cruz), mouse monoclonal anti-phospho-Histone H2A.X

(1:500, 05-636, Sigma-Aldrich).

To isolate RNA, 20-30 mg lung tissue was homogenized in Trizol (Life Technologies) with Tissue Lyzer II (Qiagen) and processed with RNeasy kit (Qiagen) according to the manufacturer's specifications. To increase the purity of the RNA extracted a convenient on-column DNase (Qiagen) treatment was performed to remove the residual amounts of DNA.

For MEFs, HeLa, and BJ cells total RNA was extracted using Maxwell® RSC Instrument, with Maxwell® RSC simplyRNA Tissue Kit (AS134, Promega), following manufacturer's instructions. NanoVue TM Plus Spectrophotometer (GE Healthcare) was used to detect RNA quantity and purity. RNA purity was ascertained via NanoVue 260/280 and 260/230 ratios.

For HBEC, total RNA was extracted using QIAGEN RNeasy Plus Kit (74034. Qiagen) following manufacturer's instructions. NanoDrop spectrophotometer was used to detect RNA quantity and purity. RNA purity was ascertained via NanoDrop 260/280 and 260/230 ratios.

For MEFs, HeLa and BJ 1-2 μg of total cell RNA was reverse transcribed into cDNA using SuperScript VILO cDNA Synthesis Kit (11754050, ThermoFisher). A volume corresponding to 25-50 ng of cDNA was used for each RT-qPCR reaction using Roche LightCycler 480 SYBR Green I Master (04707516001, Roche) sequence detection system. Each reaction was performed in triplicate.

Primers sequences (5'-3' orientation) were:

Total ACE2 as described in (Ludlow et al, 2014) .

Primer sequences (5'-3' orientation) were: ACE2 Forward Primer: TGTTGGGGAAATCATGTCACT ACE2 Reverse Primer: GAGCAGGAAGTTTATTTCTGTTTCA Amplicon size was 112 nt. Primers were designed, via primer-blast (Ye et al, 2012) and

Roche assay design center, to be intron spanning and specific to ACE2 mRNA.

Detection of tdilncRNAs was performed as previously described (Rossiello et al, 2017) , with some modifications. Briefly, RNA samples were treated with DNase I (Thermo Scientific) at 37 °C for 1 h. Next, 1 μg of total RNA was reverse transcribed using the Superscript First Strand cDNA synthesis kit (Invitrogen) with strand-specific primers.

cDNA was passed on a MicroSpin™ G-50 columns (Cytiva) and qPCR was performed using SYBR Green I Master Mix (Roche). A volume of cDNA corresponding to 20 ng of initial RNA was used. Each reaction was performed in triplicate. Rplp0 was used as a control gene for normalization. Luciferase activity was normalized on total protein quantities.

Single-cell transcriptomic data from ageing tissues in the mouse lung were downloaded from Tabula Muris Senis (https://cellxgene.cziscience.com/collections/0b9d8a04-bb9d-44da-aa27705bb65b54eb (Almanzar et al, 2020) ). Seurat (v4.0.1, (Hao et al, 2020) ) was used for downstream analyses.

The tool Pscan (Zambelli et al, 2009 ) was used to look for over-represented transcription factor binding site motifs in nucleotide sequences. TFBS motifs for the human Ace2 gene (refseq ID: NM_021804) were searched around -450 +50 of the TSS, using the Jaspar 2018_NR matrix as a descriptor.

The EnrichR tool (Kuleshov et al, 2016) was used to perform a gene set enrichment analysis of the resulting Top100 significantly over-represented transcription factors.

Results are shown as mean ± s.e.m. or s.d. or percentages ±95% confidence interval as indicated. P value was calculated by the indicated statistical tests, using Prism software. P values for single cell data analyses were calculated using the indicated statistical tests using the R software environment or with the default tests of the tools used.

We thank Joachim Lingner and Marco Giorgio for sharing reagents and all F. non-irradiated 1 Gy 5 Gy dsRed 53BP1

Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson-Gilford Progeria Syndrome

A single-cell transcriptomic atlas characterizes ageing tissues in the mouse

COVID-19: angiotensinconverting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection

Telomere shortening and tumor formation by mouse cells lacking telomerase RNA

A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection

DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion

Antisense technology: an overview and prospectus

A DNA damage checkpoint response in telomere-initiated senescence

Determinants of telomere length across human tissues

Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation

P66SHC deletion improves fertility and progeric phenotype of late-generation TERC-deficient mice but not their short lifespan

A quantitative telomeric chromatin isolation protocol identifies different telomeric states

Integrated analysis of multimodal single-cell data Yuhan

Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21CIP1, but not p16INK4a

Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence

Telomere shortening is proportional to the size of the G-rich telomeric 3'-overhang

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Essential role of mouse telomerase in highly proliferative organs

Quantitative telomerase enzyme activity determination using droplet digital PCR with single cell resolution

Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea

Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks

A twostep mechanism for TRF2-mediated chromosome-end protection

How shelterin protects mammalian telomeres

Long-term culture and cloning of primary human bronchial basal cells that maintain multipotent differentiation capacity and CFTR channel function

Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging

DNA damage response inhibition at dysfunctional telomeres by modulation of telomeric DNA damage response RNAs

Longevity, stress response, and cancer in aging telomerase-deficient mice

Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Age-and genderrelated difference of ACE2 expression in rat lung

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction

Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice

Pscan: Finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues